PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
27-Nov-2020 Nanoform Finland Plc, Interim Report January - September 2020, November 27th, 2020 at 08:00 a.m. Finnish time Nanoform
27-Nov-2020 European Medicines Agency Validates Application for Tepotinib for the Treatment of Advanced NSCLC with METex14 Skipping Alterations Merck
26-Nov-2020 Medios AG: Sales increase to more than €1 billion through acquisition of Cranach Pharma GmbH Medios AG
26-Nov-2020 Medios AG acquires Cranach Pharma GmbH; issue of 4,180,000 new Medios shares; significant increase in sales expected in 2021 to over €1 billion Medios AG
26-Nov-2020 Asklepios Kliniken: Consolidated net operating income impacted by continuing coronavirus pandemic Asklepios Kliniken
26-Nov-2020 STRATEC SE APPOINTS NEW SUPERVISORY BOARD CHAIR STRATEC SE
26-Nov-2020 New branding for a new vision: DocMorris Zur Rose Group AG
26-Nov-2020 InDex Pharmaceuticals to host virtual R&D day on December 8, 2020 InDex Pharmaceuticals
26-Nov-2020 Dompé and The Farmamondo Group: Exclusive Agreement to Distribute Oxervate™ in Russia and Other CIS Countries Dompé farmaceutici S.p.A
26-Nov-2020 Vifor Pharma supports Iron Deficiency Day 2020 to highlight global impact on health and gender inequality Vifor Pharma
26-Nov-2020 Genmab Announces Enapotamab Vedotin Update Genmab
26-Nov-2020 ABPI response to the Spending Review ABPI
26-Nov-2020 Biotest AG: Biotests Pentaglobin(R) is a treatment option for COVID-19 patients additionally affected by bacterial infections Biotest AG
26-Nov-2020 Vivoryon Therapeutics AG: Vivoryon Therapeutics Reports Third Quarter 2020 Vivoryon Therapeutics AG
26-Nov-2020 Approval of Phase I/II Clinical Trial of ATG-016 (Eltanexor), a Second Generation Selective Inhibitor of Nuclear Export (SINE), in Mainland China for the Treatment of Myelodysplastic Syndrome Antengene Corporation Limited
25-Nov-2020 Correction: NeuroRx and Relief announce initial successful results from expanded access use of RLF-100(TM) (aviptadil) in patients with Critical COVID-19 and Severe Comorbidity: 72% survival seen in ICU patients RELIEF THERAPEUTICS Holdings AG
25-Nov-2020 DTx Pharma to Present at Several Upcoming Virtual Events DTx Pharma
25-Nov-2020 TrakCel completes proof of concept phase for orchestration solution integration with UK NHS partners. TrakCel
25-Nov-2020 Sensyne Health and Hampshire Hospitals NHS Foundation Trust sign Strategic Research Agreement Sensyne Health
25-Nov-2020 Karyopharm Announces Ongoing Phase 3 SIENDO Study of XPOVIO® (Selinexor) in Patients with Endometrial Cancer Passes Planned Interim Futility Analysis: Data and Safety Monitoring Board Recommends the Study Should Proceed as Planned Without Any Modifications Karyopharm Therapeutics Inc.